BenzaClin
Links shared publicly online about this topic
Valeant snaps up Sanofi's Dermik for $425M - FiercePharma
fiercepharma.com — “Sanofi ($SNY) has agreed to offload its Dermik skincare business to Valeant Pharmaceuticals ($VRX) in a $425 million deal that gives the Canadian drugmaker brands such as the acne treatment BenzaClin Read more...” View full resource at fiercepharma.com
Most Recently Shared on July 11, 2011 at 3:16 pm By:
Valeant snaps up Sanofi's Dermik for $425M. http://bit.ly/o7OpIG
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
FiercePharma
FiercePharma's 140. Join 50,000 pharma insiders on our free newsletter at FiercePharma.com
Advertisement
